This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Fedora Pharmaceuticals Inc.
Drug Names(s): FPI-1465
Description: FPI-1465 is a ß-Lactamase inhibitor that has the ability to re-sensitize resistant bacteria to currently used ß-lactam antibiotics.
Fedora and NAEJA
In March 2012, Fedora Pharmaceuticals announced the Companys incorporation and in-license of exclusive worldwide rights to a family of beta-lactamase inhibitors (BLIs) discovered by scientists at NAEJA Pharmaceuticals.
Partners: NAEJA Pharmaceuticals Inc.
Additional information available to subscribers only: